PDF下载 ( 102 KB)
Association between intestinal dysbacteriosis and liver diseases
-
摘要:
目前研究证实肝脏疾病与肠道微生物密切相关,通过调控肠道微生物构成可影响肝脏疾病的进展和治疗效果。针对肠道菌群失调对肝脏相关疾病如酒精性肝病、非酒精性肝病及急性肝损伤的影响机制,总结了国内外研究成果,并对肝脏疾病失代偿期所引起常见并发症肝性脑病、自发性腹膜炎进行总结和讨论,为以后改进肝脏相关性疾病治疗提供新的策略。
Abstract:At present, studies have confirmed the closely relationship between liver diseases and intestinal flora, and regulation of intestinal flora has a certain effect on the progression and therapeutic outcome of liver diseases. With reference to the influencing mechanism of intestinal dysbacteriosis on liver diseases such as alcoholic liver disease, non-alcoholic liver disease, and acute liver injury, this article reviews the research advances in China and foreign countries and summarizes the complications of decompensated liver diseases, such as hepatic encephalopathy and spontaneous bacterial peritonitis, in order to provide new strategies for the treatment of liver diseases in future.
-
Key words:
- gut microbiota /
- liver diseases /
- review
-
[1]KUNTZEN C, SCHWABE RF.Gut microbiota and Toll-like receptors set the stage for cytokine-mediated failure of antibacterial responses in the fibrotic liver[J].GUT, 2017, 66 (3) :396-398. [2]XIE G, ZHONG W, ZHENG X, et al.Chronic ethanol consumption alters mammalian gastrointestinal content metabolites[J].J Proteome Res, 2013, 12 (7) :3297-3306. [3]ENGEN PA, GREEN SJ, VOIGT RM, et al.The Gastrointestinal Microbiome:Alcohol Effects on the Composition of Intestinal Microbiota[J].Alcohol Res, 2015, 37 (2) :223-236. [4]BULL-OTTERSON L, FENG W, KIRPICH I, et al.Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment[J].PLo S One, 2013, 8 (1) :e53028. [5]MUTLU EA, GILLEVET PM, RANGWALA H, et al.Colonic microbiome is altered in alcoholism[J].Am J Physiol Gastrointest Liver Physiol, 2012, 302 (9) :g966-g978. [6]MASLOWSKI KM, VIEIRA AT, NG A, et al.Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J].Nature, 2009, 461 (7268) :1282-1286. [7]KIM MH, KANG SG, PARK JH, et al.Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice[J].Gastroenterology, 2013, 145 (2) :396-406. [8]COTILLARD A, KENNEDY SP, KONG LC, et al.Dietary intervention impact on gut microbial gene richness[J].Nature, 2013, 500 (7464) :585-588. [9] QIN N, YANG F, LI A, et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature, 2014, 513 (7516) :59-64. [10]COUCH RD, DAILEY A, ZAIDI F, et al.Alcohol induced alterations to the human fecal VOC metabolome[J].PLo S One, 2015, 10 (3) :e119362. [11]DUNAGAN M, CHAUDHRY K, SAMAK G, et al.Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism[J].Am J Physiol Gastrointest Liver Physiol, 2012, 303 (12) :g1356-g1364. [12]WANG Y, TONG J, CHANG B, et al.Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junctionassociated proteins[J].Mol Med Rep, 2014, 9 (6) :2352-2356. [13]DAVID BA, REZENDE RM, ANTUNES MM, et al.Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice[J].Gastroenterology, 2016, 151 (6) :1176-1191. [14]SZABO G.Gut-liver axis in alcoholic liver disease[J].Gastroenterology, 2015, 148 (1) :30-36. [15]ROH YS, ZHANG B, LOOMBA R, et al.TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1and neutrophil infiltration[J].Am J Physiol Gastrointest Liver Physiol, 2015, 309 (1) :g30-g41. [16]WANG Y, LIU Y, KIRPICH I, et al.Lactobacillus rhamnosus GG reduces hepatic TNFalpha production and inflammation in chronic alcohol-induced liver injury[J].J Nutr Biochem, 2013, 24 (9) :1609-1615. [17]SZABO G, PETRASEK J.Gut-liver axis and sterile signals in the development of alcoholic liver disease[J].Alcohol Alcohol, 2017, 52 (4) :414-424. [18]BASHIARDES S, SHAPIRO H, ROZIN S, et al.Non-alcoholic fatty liver and the gut microbiota[J].Mol Metab, 2016, 5 (9) :782-794. [19]BACKHED F, MANCHESTER JK, SEMENKOVICH CF, et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J].Proc Natl Acad Sci U S A, 2007, 104 (3) :979-984. [20]MIURA K, OHNISHI H.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease[J].World J Gastroenterol, 2014, 20 (23) :7381-7391. [21]NAKAMOTO N, KANAI T.Role of toll-like receptors in immune activation and tolerance in the liver[J].Frontiers in Immunology, 2014, 5:221. [22]DIXON LJ, BERK M, THAPALIYA S, et al.Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis[J].Lab Invest, 2012, 92 (5) :713-723. [23]YANG G, LEE HE, LEE JY.A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet[J].Sci Rep, 2016, 6:24399. [24]BACH KK.Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health[J].Adv Nutr, 2015, 6 (2) :206-213. [25]KIMURA I, OZAWA K, INOUE D, et al.The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J].Nat Commun, 2013, 4:1829. [26]SAYIN SI, WAHLSTROM A, FELIN J, et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J].Cell Metab, 2013, 17 (2) :225-235. [27]de AGUIAR VT, TARLING EJ, EDWARDS PA.Pleiotropic roles of bile acids in metabolism[J].Cell Metab, 2013, 17 (5) :657-669. [28]CIPRIANI S, MENCARELLI A, PALLADINO G, et al.FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats[J].J Lipid Res, 2010, 51 (4) :771-784. [29]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437. [30]BAJAJ JS, O'LEARY JG, REDDY KR, et al.Second infections independently increase mortality in hospitalized patients with cirrhosis:the North American consortium for the study of end-stage liver disease (NACSELD) experience[J].Hepatology, 2012, 56 (6) :2328-2335. [31]BAJAJ JS, HEUMAN DM, HYLEMON PB, et al.Altered profile of human gut microbiome is associated with cirrhosis and its complications[J].J Hepatol, 2014, 60 (5) :940-947. [32]CHEN Y, GUO J, QIAN G, et al.Gut dysbiosis in acute-onchronic liver failure and its predictive value for mortality[J].J Gastroenterol Hepatol, 2015, 30 (9) :1429-1437. [33]YU LX, SCHWABE RF.The gut microbiome and liver cancer:mechanisms and clinical translation[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (9) :527-539. [34]EL-SERAG HB.Hepatocellular carcinoma[J].N Engl J Med, 2011, 365 (12) :1118-1127. [35]SINGAL AG, EL-SERAG HB.Hepatocellular carcinoma from epidemiology to prevention:translating knowledge into practice[J].Clin Gastroenterol Hepatol, 2015, 13 (12) :2140-2151. [36]HAN ML, GONG ZH.Mechanism of action of gut microbiota in hepatobiliary diseases[J].J Clin Hepatol, 2017, 33 (2) :384-388. (in Chinese) 韩美林, 龚振华.肠道菌群在肝胆疾病中的作用机制[J].临床肝胆病杂志, 2017, 33 (2) :384-388. [37]PRADERE JP, TROEGER JS, DAPITO DH, et al.Toll-like receptor 4 and hepatic fibrogenesis[J].Semin Liver Dis, 2010, 30 (3) :232-244. [38]BAJAJ JS, BETRAPALLY NS, GILLEVET PM.Decompensated cirrhosis and microbiome interpretation[J].Nature, 2015, 525 (7569) :e1-e2. [39]QIN N, YANG F, LI A, et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature, 2014, 513 (7516) :59-64. [40]VILSTRUP H, AMODIO P, BAJAJ J, et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology, 2014, 60 (2) :715-735. [41] LACHAR J, BAJAJ JS.Changes in the microbiome in cirrhosis and relationship to complications:hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis[J].Semin Liver Dis, 2016, 36 (4) :327-330. [42]KANG DJ, BETRAPALLY NS, GHOSH SA, et al.Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice[J].Hepatology, 2016, 64 (4) :1232-1248. [43]BAJAJ JS, BETRAPALLY NS, HYLEMON PB, et al.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy[J].Hepatology, 2015, 62 (4) :1260-1271. [44]KHANNA S, TOSH PK.A clinician's primer on the role of the microbiome in human health and disease[J].Mayo Clin Proc, 2014, 89 (1) :107-114. [45]WANG GY, WANG GC.Reasearch progress of associated susceptible factors of spontaneous bacterial peritonitis in hepatic cirrhosis[J/CD].Chin J Liver Dis:Electronic Edition, 2016, 8 (2) :5-8. (in Chinese) 王贵云, 王拱辰.肝硬化并发自发性腹膜炎相关易感因素的研究进展[J/CD].中国肝脏病杂志:电子版, 2016, 8 (2) :5-8. [46]LU L.Risk factors of liver cirrhosis ascites complicated with spontaneous bacterial peritonitis[J].China Med Herald, 2016, 13 (8) :140-142. (in Chinese) 陆琳.肝硬化腹水并发自发性腹膜炎的危险因素[J].中国医药导报, 2016, 13 (8) :140-142. [47]LACHAR J, BAJAJ JS.Changes in the microbiome in cirrhosis and relationship to complications:hepatic encephalopathy, spontaneous bacterial peritonitis, and sepsis[J].Semin Liver Dis, 2016, 36 (4) :327-330. [48]TUOMISTO S, PESSI T, COLLIN P, et al.Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics[J].BMC Gastroenterol, 2014, 14:40. [49]SANTIAGO A, POZUELO M, POCA M, et al.Alteration of the serum microbiome composition in cirrhotic patients with ascites[J].Sci Rep, 2016, 6:25001. [50]LUAN YT, CAI WJ, XU Y, et al.Role of intestinal flora in the development and progression of spontaneous bacterial peritonitis[J].J Clin Hepatol, 2016, 32 (8) :1622-1625. (in Chinese) 栾雨婷, 蔡文君, 徐莹, 等.肠道菌群在自发性细菌性腹膜炎发生发展中的作用[J].临床肝胆病杂志, 2016, 32 (8) :1622-1625. [51]CHANDER RB, GARCIA-TSAO G, CIARLEGLIO MM, et al.Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls[J].J Clin Gastroenterol, 2013, 47 (10) :888-893. -
本文二维码
计量
- 文章访问数: 2648
- HTML全文浏览量: 36
- PDF下载量: 553
- 被引次数: 0
下载:
